Global Orthobiologics Market Size study & Forecast, by Product Type (Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix (DBM), Synthetic Bone Substitutes, Cellular Allograft, Allografts, and Others), By Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery, and Others), By End-user (Hospitals & Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Others) and Regional Analysis, 2022-2029
Global Orthobiologics Market is valued at approximately USD 7.63 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.4 % over the forecast period 2022-2029. Orthobiologics and regenerative medicines are frequently made from substances naturally present in the body and used to speed the healing process after injuries. These products are used in orthopaedic procedures to speed the healing of injured muscles, ligaments, and tendons as well as broken bones. The key factors driving the market growth are rising cases of Orthopedic Injuries, increasing aging population, and growing sports injuries. Thus, creating demand for the Orthobiologics market during the forecast period.
The primary factors most likely to drive up demand for orthobiologics products are the rapid increase in orthopaedic injuries and musculoskeletal diseases that cause severe physical pain and limited mobility. According to data from the American Academy of Orthopedic Surgeons, more than 6.8 million patients in the U.S. alone visit a doctor each year for orthopaedic injuries. This large patient base that requires orthopaedic injury therapy may drive market expansion during the forecasted period. Also, rising product development by market players propels the market growth forward. For instance, in 2020, Royal Biologics officially launched MAGNUS, a dimethyl sulfoxide (DMSO) free viable cellular bone allograft. Additionally, rising investment in healthcare infrastructure would create a lucrative opportunity for the market during the forecast period. However, the high cost of orthobiologics products stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Orthobiologics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to introduction of synthetic products by market players and rising adoption of biologics for bone-related injuries & disorders in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as increasing geriatric population, surge in obesity, and growing awareness related to the use of orthobiologics.
Major market players included in this report are:
Medtronic (Ireland)
Zimmer Biomet (U.S.)
DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.)
Stryker (U.S.)
Anika Therapeutics, Inc. (U.S.)
SeaSpine (U.S.)
Bioventus (U.S.)
RTI Surgical (U.S.)
MTF Biologics (U.S.)
Arthrex, Inc. (U.S.)
Recent Developments in the Market:
In 2019, Medtronic announced the launch of its Grafton Demineralized Bone Matrix (DBM) in Japan. The spine and orthopaedic treatments use this bone graft.
In 2021, For its fibergaft bone graft alternatives, which are used in spinal fusion surgeries, Prosidyan received CE mark certifications.
Global Orthobiologics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Viscosupplements
Bone Growth Factors
Demineralized Bone Matrix (DBM)
Synthetic Bone Substitutes
Cellular Allograft
Allografts
Others
By Application:
Spinal Fusion
Maxillofacial & Dental
Soft Tissue Repair
Reconstructive & Fracture Surgery
Others
By End-user:
Hospitals & Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The primary factors most likely to drive up demand for orthobiologics products are the rapid increase in orthopaedic injuries and musculoskeletal diseases that cause severe physical pain and limited mobility. According to data from the American Academy of Orthopedic Surgeons, more than 6.8 million patients in the U.S. alone visit a doctor each year for orthopaedic injuries. This large patient base that requires orthopaedic injury therapy may drive market expansion during the forecasted period. Also, rising product development by market players propels the market growth forward. For instance, in 2020, Royal Biologics officially launched MAGNUS, a dimethyl sulfoxide (DMSO) free viable cellular bone allograft. Additionally, rising investment in healthcare infrastructure would create a lucrative opportunity for the market during the forecast period. However, the high cost of orthobiologics products stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Orthobiologics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to introduction of synthetic products by market players and rising adoption of biologics for bone-related injuries & disorders in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as increasing geriatric population, surge in obesity, and growing awareness related to the use of orthobiologics.
Major market players included in this report are:
Medtronic (Ireland)
Zimmer Biomet (U.S.)
DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.)
Stryker (U.S.)
Anika Therapeutics, Inc. (U.S.)
SeaSpine (U.S.)
Bioventus (U.S.)
RTI Surgical (U.S.)
MTF Biologics (U.S.)
Arthrex, Inc. (U.S.)
Recent Developments in the Market:
In 2019, Medtronic announced the launch of its Grafton Demineralized Bone Matrix (DBM) in Japan. The spine and orthopaedic treatments use this bone graft.
In 2021, For its fibergaft bone graft alternatives, which are used in spinal fusion surgeries, Prosidyan received CE mark certifications.
Global Orthobiologics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Viscosupplements
Bone Growth Factors
Demineralized Bone Matrix (DBM)
Synthetic Bone Substitutes
Cellular Allograft
Allografts
Others
By Application:
Spinal Fusion
Maxillofacial & Dental
Soft Tissue Repair
Reconstructive & Fracture Surgery
Others
By End-user:
Hospitals & Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Orthobiologics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Orthobiologics Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Orthobiologics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Orthobiologics Market, by End-user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ORTHOBIOLOGICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ORTHOBIOLOGICS MARKET DYNAMICS
3.1. Orthobiologics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising cases of Orthopedic Injuries
3.1.1.2. Increasing aging population
3.1.2. Market Challenges
3.1.2.1. High Cost of Orthobiologics
3.1.3. Market Opportunities
3.1.3.1. Improvement in healthcare infrastructure
CHAPTER 4. GLOBAL ORTHOBIOLOGICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT TYPE
6.1. Market Snapshot
6.2. Global Orthobiologics Market by Product Type, Performance - Potential Analysis
6.3. Global Orthobiologics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Orthobiologics Market, Sub Segment Analysis
6.4.1. Viscosupplements
6.4.2. Bone Growth Factors
6.4.3. Demineralized Bone Matrix (DBM)
6.4.4. Synthetic Bone Substitutes
6.4.5. Cellular Allograft
6.4.6. Allografts
6.4.7. Others
CHAPTER 7. GLOBAL ORTHOBIOLOGICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Orthobiologics Market by Application, Performance - Potential Analysis
7.3. Global Orthobiologics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Orthobiologics Market, Sub Segment Analysis
7.4.1. Spinal Fusion
7.4.2. Maxillofacial & Dental
7.4.3. Soft Tissue Repair
7.4.4. Reconstructive & Fracture Surgery
7.4.5. Others
CHAPTER 8. GLOBAL ORTHOBIOLOGICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Orthobiologics Market by End-user, Performance - Potential Analysis
8.3. Global Orthobiologics Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
8.4. Orthobiologics Market, Sub Segment Analysis
8.4.1. Hospitals & Ambulatory Surgical Centers (ASCs)
8.4.2. Specialty Clinics
8.4.3. Others
CHAPTER 9. GLOBAL ORTHOBIOLOGICS MARKET, REGIONAL ANALYSIS
9.1. Orthobiologics Market, Regional Market Snapshot
9.2. North America Orthobiologics Market
9.2.1. U.S. Orthobiologics Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Orthobiologics Market
9.3. Europe Orthobiologics Market Snapshot
9.3.1. U.K. Orthobiologics Market
9.3.2. Germany Orthobiologics Market
9.3.3. France Orthobiologics Market
9.3.4. Spain Orthobiologics Market
9.3.5. Italy Orthobiologics Market
9.3.6. Rest of Europe Orthobiologics Market
9.4. Asia-Pacific Orthobiologics Market Snapshot
9.4.1. China Orthobiologics Market
9.4.2. India Orthobiologics Market
9.4.3. Japan Orthobiologics Market
9.4.4. Australia Orthobiologics Market
9.4.5. South Korea Orthobiologics Market
9.4.6. Rest of Asia Pacific Orthobiologics Market
9.5. Latin America Orthobiologics Market Snapshot
9.5.1. Brazil Orthobiologics Market
9.5.2. Mexico Orthobiologics Market
9.5.3. Rest of Latin America Orthobiologics Market
9.6. Rest of The World Orthobiologics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Medtronic (Ireland)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Zimmer Biomet (U.S.)
10.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.)
10.2.4. Stryker (U.S.)
10.2.5. Anika Therapeutics, Inc. (U.S.)
10.2.6. SeaSpine (U.S.)
10.2.7. Bioventus (U.S.)
10.2.8. RTI Surgical (U.S.)
10.2.9. MTF Biologics (U.S.)
10.2.10. Arthrex, Inc. (U.S.)
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Orthobiologics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Orthobiologics Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Orthobiologics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Orthobiologics Market, by End-user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ORTHOBIOLOGICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ORTHOBIOLOGICS MARKET DYNAMICS
3.1. Orthobiologics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising cases of Orthopedic Injuries
3.1.1.2. Increasing aging population
3.1.2. Market Challenges
3.1.2.1. High Cost of Orthobiologics
3.1.3. Market Opportunities
3.1.3.1. Improvement in healthcare infrastructure
CHAPTER 4. GLOBAL ORTHOBIOLOGICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT TYPE
6.1. Market Snapshot
6.2. Global Orthobiologics Market by Product Type, Performance - Potential Analysis
6.3. Global Orthobiologics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Orthobiologics Market, Sub Segment Analysis
6.4.1. Viscosupplements
6.4.2. Bone Growth Factors
6.4.3. Demineralized Bone Matrix (DBM)
6.4.4. Synthetic Bone Substitutes
6.4.5. Cellular Allograft
6.4.6. Allografts
6.4.7. Others
CHAPTER 7. GLOBAL ORTHOBIOLOGICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Orthobiologics Market by Application, Performance - Potential Analysis
7.3. Global Orthobiologics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Orthobiologics Market, Sub Segment Analysis
7.4.1. Spinal Fusion
7.4.2. Maxillofacial & Dental
7.4.3. Soft Tissue Repair
7.4.4. Reconstructive & Fracture Surgery
7.4.5. Others
CHAPTER 8. GLOBAL ORTHOBIOLOGICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Orthobiologics Market by End-user, Performance - Potential Analysis
8.3. Global Orthobiologics Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
8.4. Orthobiologics Market, Sub Segment Analysis
8.4.1. Hospitals & Ambulatory Surgical Centers (ASCs)
8.4.2. Specialty Clinics
8.4.3. Others
CHAPTER 9. GLOBAL ORTHOBIOLOGICS MARKET, REGIONAL ANALYSIS
9.1. Orthobiologics Market, Regional Market Snapshot
9.2. North America Orthobiologics Market
9.2.1. U.S. Orthobiologics Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Orthobiologics Market
9.3. Europe Orthobiologics Market Snapshot
9.3.1. U.K. Orthobiologics Market
9.3.2. Germany Orthobiologics Market
9.3.3. France Orthobiologics Market
9.3.4. Spain Orthobiologics Market
9.3.5. Italy Orthobiologics Market
9.3.6. Rest of Europe Orthobiologics Market
9.4. Asia-Pacific Orthobiologics Market Snapshot
9.4.1. China Orthobiologics Market
9.4.2. India Orthobiologics Market
9.4.3. Japan Orthobiologics Market
9.4.4. Australia Orthobiologics Market
9.4.5. South Korea Orthobiologics Market
9.4.6. Rest of Asia Pacific Orthobiologics Market
9.5. Latin America Orthobiologics Market Snapshot
9.5.1. Brazil Orthobiologics Market
9.5.2. Mexico Orthobiologics Market
9.5.3. Rest of Latin America Orthobiologics Market
9.6. Rest of The World Orthobiologics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Medtronic (Ireland)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Zimmer Biomet (U.S.)
10.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.)
10.2.4. Stryker (U.S.)
10.2.5. Anika Therapeutics, Inc. (U.S.)
10.2.6. SeaSpine (U.S.)
10.2.7. Bioventus (U.S.)
10.2.8. RTI Surgical (U.S.)
10.2.9. MTF Biologics (U.S.)
10.2.10. Arthrex, Inc. (U.S.)
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Orthobiologics Market, report scope
TABLE 2. Global Orthobiologics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Orthobiologics Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Orthobiologics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Orthobiologics Market estimates & forecasts by End-user 2019-2029 (USD Billion)
TABLE 6. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Orthobiologics Market
TABLE 71. List of primary sources, used in the study of global Orthobiologics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Orthobiologics Market, report scope
TABLE 2. Global Orthobiologics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Orthobiologics Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Orthobiologics Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Orthobiologics Market estimates & forecasts by End-user 2019-2029 (USD Billion)
TABLE 6. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Orthobiologics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Orthobiologics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Orthobiologics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Orthobiologics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Orthobiologics Market
TABLE 71. List of primary sources, used in the study of global Orthobiologics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Orthobiologics Market, research methodology
FIG 2. Global Orthobiologics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Orthobiologics Market, key trends 2021
FIG 5. Global Orthobiologics Market, growth prospects 2022-2029
FIG 6. Global Orthobiologics Market, porters 5 force model
FIG 7. Global Orthobiologics Market, pest analysis
FIG 8. Global Orthobiologics Market, value chain analysis
FIG 9. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Orthobiologics Market, regional snapshot 2019 & 2029
FIG 15. North America Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 19. Global Orthobiologics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Orthobiologics Market, research methodology
FIG 2. Global Orthobiologics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Orthobiologics Market, key trends 2021
FIG 5. Global Orthobiologics Market, growth prospects 2022-2029
FIG 6. Global Orthobiologics Market, porters 5 force model
FIG 7. Global Orthobiologics Market, pest analysis
FIG 8. Global Orthobiologics Market, value chain analysis
FIG 9. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Orthobiologics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Orthobiologics Market, regional snapshot 2019 & 2029
FIG 15. North America Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Orthobiologics Market 2019 & 2029 (USD Billion)
FIG 19. Global Orthobiologics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
